000 | 01707 a2200541 4500 | ||
---|---|---|---|
005 | 20250516103640.0 | ||
264 | 0 | _c20130103 | |
008 | 201301s 0 0 eng d | ||
022 | _a1873-2623 | ||
024 | 7 |
_a10.1016/j.transproceed.2012.05.069 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSolak, I | |
245 | 0 | 0 |
_aSpousal versus living unrelated renal transplantation: a retrospective analysis of allograft outcomes. _h[electronic resource] |
260 |
_bTransplantation proceedings _c |
||
300 |
_a1710-2 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aABO Blood-Group System |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _ximmunology |
650 | 0 | 4 |
_aGraft Survival _xdrug effects |
650 | 0 | 4 | _aHistocompatibility |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
650 | 0 | 4 | _aLiving Donors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSpouses |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aTurkey |
700 | 1 | _aSezer, T O | |
700 | 1 | _aToz, H | |
700 | 1 | _aTatar, E | |
700 | 1 | _aIsayev, C | |
700 | 1 | _aFirat, O | |
700 | 1 | _aHoscoskun, C | |
773 | 0 |
_tTransplantation proceedings _gvol. 44 _gno. 6 _gp. 1710-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2012.05.069 _zAvailable from publisher's website |
999 |
_c21981611 _d21981611 |